Glucagon-like peptide 1 receptor agonists (GLP-1RAs) were originally developed to treat type 2 diabetes, but are becoming increasingly popular for the treatment of obesity because they are effective at helping people lose weight
The resource you are looking for might have been removed, had its name changed, or is temporarily unavailable.
Weight loss, dietary modifications, increased physical activity, or changes in other medications can all influence diabetes control and may necessitate dose adjustments
The US Preventive Services Task Force recommends screening adults aged 35-70 years with overweight or obesity for prediabetes and diabetes
A big part of the cost comes down to the drugs development, which involved years of rigorous clinical trials, not to mention the higher cost of manufacturing the prefilled pens versus a simpler delivery method like a pill